Lipocine Inc.·4

Dec 22, 7:20 PM ET

Patel Mahesh V. 4

4 · Lipocine Inc. · Filed Dec 22, 2022

Insider Transaction Report

Form 4
Period: 2022-12-22
Patel Mahesh V.
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-12-22$0.41/sh+112,500$46,1252,242,395 total
    Exercise: $0.41From: 2023-12-22Exp: 2032-12-22Common Stock (112,500 underlying)
Footnotes (1)
  • [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 22, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years.

Documents

1 file
  • 4
    ownership.xmlPrimary